About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

OPTIMIZATION of ADVANCED MR SEQUENCES | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05618990

OPTIMIZATION of ADVANCED MR SEQUENCES

This monocentric methodological study aims at optimizing advanced MR sequences for image quality (reduced artefacts, signal to noise ratio, acquisition time, stability of quantitative measurements) on...

Lead sponsor: Centre Hospitalier St Anne•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Khaoussou SYLLA

CONTACT

01 45 65 76 78 k.sylla@ghu-paris.fr

Viviane AWASSI

CONTACT

01 45 65 84 86 v.awassi@ghu-paris.fr

Sponsors

Lead Sponsor

Centre Hospitalier St Anne

Primary goal : Optimization of MR protocols and validation of acquisition parameters of advanced MR sequences on healthy volunteers or patients on a new 3T MR unit dedicated to research in neurosciences. Secondary goals 1. Perform acquisitions to validate the feasibility of research MR protocols (pilot subjects) 2. reproducibility studies

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•18 ans
•Covered by social security
•For women in age of procreation, under efficient contraception
•Written consent

Exclusion Criteria

•Any MR contraindication
•Claustrophobia
•Pregnancy
•Under judiciary protection

Related studies

Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management

NCT06755697 · Knee Osteoarthritis, Glucose, and more

RECRUITINGPhase 3

Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

NCT06905587 · Brain Tumor, Pediatric, Cancer-related Fatigue, and more

RECRUITINGPhase 2

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

NCT06962215 · Brain Tumor Adult

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 10, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment300

Start dateNov 2019

Last updatedJul 10, 2024

Condition

Neurosciences MRI Brain Tumor Mental Disorders Stroke

Locations shown

OPPENHEIM Catherine

Paris

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 10, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions